AzTrials
AzTrials

Critical IllnessNCT03216993

An Early Enteral Nutrition Protocol in Shanghai

A study testing Protocol care in people with Critical Illness and Enteral Feeding Intolerance, run by Ruijin Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

compare different enteral nutrition strategy in patients with mechanical ventilation Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Critical Illness, Enteral Feeding Intolerance
What is being tested?
Protocol care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
400 participants
Where
1 siteChina
Study dates
1 Dec 2018to 1 Oct 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ICU patients
  • Receiving mechanical ventilation (MV) both Non-invasive ventilation and invasive ventilation
  • Expecting MV more than 72 hours

Who cannot join

  • Pregnancy
  • ICU stay < 72hr

Trial locations and contacts

1 site in 1 country.

Hongping Qu, Doctor contact

+8618917762330

qhp10516@rjh.com.cn

Ming Zhong, Master contact

+8613564626325

zm11716@rjh.com.cn

China1 site
  • Ruijin

    Shanghai, Shanghai Municipality, 20000

Other trials in China

About this study

Official title: The Shanghai Protocol for Early Enteral Nutrition in Mechanical Ventilated Patients

compare different enteral nutrition strategy in patients with mechanical ventilation

Read the detailed description

There has been many evidence that deficiency in energy and protein take-in are associated with poor outcome in critical patients. To reach an adequate amount of energy and protein is critical in patients with respiratory failure and with mechanical ventilation, as it prevents muscle dystrophy and thus prevents ICU acquired weakness, leading to a better outcome in the end. Enteral Nutrition is preferred as it prevents gut dysfunction in respiratory failure patients, and may prevent further infection. But there are many challenge in implement a good enteral nutrition therapy, and energy or protein deficiency is common in patient with respiratory failure. There have been many protocols aiming at reaching enough enteral nutrition for ICU patients, most of which are based on a background of western and developed countries. The investigators developped a enteral nutrition protocol based on an unique cultural background of eastern developing country, trying to help the ICU patients reaching nutrition target, so that the patients may have better outcome.

Being tested
Standard care, Protocol care
Keywords
feeding protocol
Medical subject headings
Critical Illness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standard careOther

    Standard care: patients receive enteral nutrition in accordance with the usual practice in the participating units

  • Protocol careOther

    Protocol care: patient receive enteral nutrition in accordance with enteral nutrition protocol studied

Study groups in NCT03216993
Study groupRoleWhat they receive
Standard careOtherStandard care: patients receive enteral nutrition in accordance with the usual practice in the participating units
Receives: Other: Standard care
Protocol careExperimentalProtocol care: patient receive enteral nutrition in accordance with enteral nutrition protocol studied
Receives: Other: Protocol care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. energy target fulfilling rate

    the proportion of patients in both arms meeting the targeted energy in-take

    Measured: 7 days from enrollment

  2. protein target fulfilling rate

    the proportion of patients in both arms meeting the targeted protein in-take

    Measured: 7 days from enrollment

Secondary outcomes (1)
  1. mortality

    mortality

    Measured: 28 days from enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jul 2017
  2. Study start1 Dec 2018 (estimated)
  3. Primary completion31 Dec 2020 (estimated)
  4. Study completion1 Oct 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03216993
Sponsor's protocol ID
Shanghai EEN
Status last verified
Apr 2018
First submitted
8 Jul 2017
Last updated
17 Apr 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Protocol care in people with Critical Illness and Enteral Feeding Intolerance, run by Ruijin Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 Apr 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Hongping Qu, Doctor (+8618917762330, qhp10516@rjh.com.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

energy target fulfilling rate (time frame: 7 days from enrollment). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Apr 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in